The Department of Veterans Affairs, through the Network Contracting Office 6, is conducting market research for the Recor Renal Denervation system, specifically the Paradise Renal Denervation System, which utilizes ultrasound energy to treat hypertension. This specialized catheter-based device is crucial for improving patient quality of life and reducing cardiovascular hospitalizations, as it is the only FDA-approved device of its kind on the market. Interested businesses must indicate their status as small business manufacturers or resellers, provide a capabilities statement, and submit documentation proving authorization as a distributor to avoid classification as “grey market.” Responses are due by April 9, 2025, at 10 AM EST, and should be directed to Byron Brown at Byron.Brown4@va.gov.